DXCM
DexCom, Inc. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares +5.0% ·
flujo de acciones -3.1% ·
nuevas posiciones netas +4.8%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 168 | +1 | 305.13M | $20.51B | +7 | −5 |
| Q1 2026 | 169 | 0 | 297.37M | $18.71B | +3 | −4 |
| Q4 2025 | 168 | 0 | 314.09M | $20.85B | +1 | — |
| Q3 2025 | 26 | +1 | 175.97M | $11.84B | +1 | −1 |
| Q2 2025 | 23 | -1 | 152.74M | $13.33B | — | −1 |
| Q1 2025 | 21 | 0 | 61.18M | $4.17B | — | — |
| Q4 2024 | 21 | +1 | 69.06M | $5.37B | +1 | — |
| Q3 2024 | 19 | -2 | 54.56M | $3.66B | — | −2 |
| Q2 2024 | 21 | — | 52.99M | $6.01B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 16.69M | — | $1.30B | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Baillie Gifford ✦ | 14.61M | -2.7% | $1.14B | 0.9% | ▼ Trim | 3 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (pasivo) | 9.99M | +0.6% | $775.26M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasivo) | 4.96M | -1.0% | $385.37M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 4.26M | +245.4% | $331.41M | 0.3% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Capital World Investors ✦ | 3.84M | -49.6% | $298.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 3.53M | +45.3% | $274.54M | 0.3% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 3.08M | +800.3% | $239.22M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 1.94M | -39.7% | $150.84M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 10 | Point72 Asset Management ✦ | 1.60M | Nuevo | $124.34M | 0.3% | New | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 889.87K | +7.1% | $69.21M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 863.02K | +4.6% | $67.12M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 13 | Fisher Asset Management ✦ | 761.84K | -11.0% | $59.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 608.21K | +208.3% | $47.30M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 15 | Adage Capital Partners ✦ | 555.12K | +1.3% | $43.17M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 539.29K | +104.3% | $41.94M | 0.1% | ▲ Add | 3 | SEC ↗ ×3 |
| 17 | Gotham Asset Management ✦ | 114.68K | +45.5% | $8.92M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 97.94K | -69.4% | $7.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 54.83K | -32.7% | $4.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 52.00K | 0.0% | $4.04M | 0.0% | Held | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 25.84K | -99.5% | $2.01M | 0.0% | ▼ Trim | 3 | SEC ↗ ×5 |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $124.34M | 0.3% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 15.50K acciones, $973 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 2.56K acc. · $220,975
Director · 6.54K acc. · $549,538
Officer · 1.70K acc. · $142,868
Director · 1.55K acc. · $130,231
Officer · 3.64K acc. · $302,936
Officer · 2.56K acc. · $226,669
Officer, Director · 19.31K acc. · $1.73M
Officer, Director · 97 acc. · $8,867
Officer, Director · 7.35K acc. · $667,332
Officer · 1.70K acc. · $156,281
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología